Overview

Bioequivalence Study of Risperidone 1.0 mg Tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fasting Conditions

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Objective: - To assess the bioequivalence of Risperidone 1.0 mg tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg tablets of Janssen Pharmaceutical Products, LP, USA, in healthy human adult subjects, under fasting conditions. Study Design: - A randomized, open label, two treatment, two period, two sequence, single dose, crossover study, under fasting conditions.

Phase:

Phase 1

Details

Lead Sponsor:

Torrent Pharmaceuticals Limited

Treatments:

Risperidone